Genascence Corporation
PrivateLast Round
Grant
Feb 23, 2023
Total Funding Raised
$22.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Genascence Corporation is a biotechnology company developing gene therapies for prevalent musculoskeletal and joint diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genascence Corporation Comparables
Compare Genascence Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ICM Co., Ltd. | 83% | |
| Xalud Therapeutics | 83% | |
| Kolon TissueGene, Inc. | 82% |
Genascence Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 23, 2023 | ||||
| Series A | May 10, 2022 |
Key People
Founding team and executive leadership
Genascence Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DeepWork Capital | Series A |
| California Institute for Regenerative Medicine | Grant |
| University of Florida Research Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 179% MoM, from 562 to 1.6K.
- Feb 23, 2023
$12M grant received from California Institute for Regenerative Medicine.
Genascence Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genascence Corporation's valuation, stock price, and market status.
Is Genascence Corporation a public or private company?
Genascence Corporation is a private company.
What is the current stock price of Genascence Corporation?
Genascence Corporation is a private company with no public stock price. No recent secondary market data is available.
How much is Genascence Corporation worth (valuation)?
Valuation information for Genascence Corporation is not publicly available.
Can I buy Genascence Corporation stock?
Genascence Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genascence Corporation's last funding round?
Genascence Corporation's most recent funding round was Grant on February 23, 2023.
Who are the main investors in Genascence Corporation?
Key investors in Genascence Corporation include DeepWork Capital, California Institute for Regenerative Medicine, University of Florida Research Foundation.
Will Genascence Corporation IPO soon?
No public IPO plans have been announced for Genascence Corporation.
How can I track Genascence Corporation secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genascence Corporation's secondary market activity and sign up for updates.